首控(01269.HK)折讓8.8%配股還債
首控集團(01269.HK)公布,就債務資本化訂立清償協議,向15名債權人配售約1.65億股,佔公司擴大後股本約10.19%,每股代價股份0.31元,較昨日(4日)收市價0.34元折讓約8.82%。債權人應付的認購金額將透過資本化應收公司債務金額5,109.64萬元償付。
公司認為,認購事項可讓公司在毋須動用集團現有財務資源的情況下償付債務金額,以減少利息開支、減緩集團的還款壓力並減少現金流出;將擴闊公司的股東基礎及減低集團的資產負債水平。
該15名債權人全為獨立第三方,包括溫洪海、周小英、謝建新、齊子平、張志中、張鋒、陳少川、黃靖超、陳書偉、郭明翔、徐江英、尹夢葶、鄭聯軍、張國平及胡育成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.